Expert Review of Pharmacoeconomics & Outcomes Research

译名:药物经济学与结果研究专家评论

SSCISCIEJCR Q3中科院4区

1-3

2026

影响因子区间

平台估算

投稿周期

13%

2025

中国作者发文占比

2650 USD

费用说明

收费

期刊简介:Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed resultsArticle Highlights – an executive summary of the author’s most critical points.

【译文】《药物经济学与成果研究专家评论》(ISSN 1473-7167)提供关于药物和治疗方案临床应用的成本效益和药物经济学问题的专家评论。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
1473-7167
eISSN
1744-8379
出版频率
双月刊
创刊年份
1968
投稿网址
https://mc.manuscriptcentral.com/erp
最近更新
2026-04-02 18:16:40
Expert Review of Pharmacoeconomics & Outcomes Research

指标当前值近三年趋势
JCR分区Q3
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无